BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹304 Cr | ₹281 Cr | ₹251 Cr | ₹171 Cr | ₹225 Cr |
What is the latest Revenue of BAL PHARMA ?
Year | Revenue |
---|---|
Mar2023 | ₹304 Cr |
Mar2022 | ₹281 Cr |
Mar2021 | ₹251 Cr |
Mar2020 | ₹171 Cr |
Mar2019 | ₹225 Cr |
How is Revenue of BAL PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹304 Cr | 8.18 | |
Mar2022 | ₹281 Cr | 12.25 | |
Mar2021 | ₹251 Cr | 46.43 | |
Mar2020 | ₹171 Cr | -23.96 | |
Mar2019 | ₹225 Cr | - |
Compare Revenue of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹159.8 Cr | 0.1% | 2.5% | 27.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 0.1% |
2.5% |
27.1% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses